GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » PEG Ratio

RaySearch Laboratories AB (OSTO:RAY B) PEG Ratio : 3.79 (As of Jun. 19, 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, RaySearch Laboratories AB's PE Ratio without NRI is 48.18. RaySearch Laboratories AB's 5-Year EBITDA growth rate is 12.70%. Therefore, RaySearch Laboratories AB's PEG Ratio for today is 3.79.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for RaySearch Laboratories AB's PEG Ratio or its related term are showing as below:

OSTO:RAY B' s PEG Ratio Range Over the Past 10 Years
Min: 1.8   Med: 6.23   Max: 267.96
Current: 3.79


During the past 13 years, RaySearch Laboratories AB's highest PEG Ratio was 267.96. The lowest was 1.80. And the median was 6.23.


OSTO:RAY B's PEG Ratio is ranked worse than
81.14% of 228 companies
in the Healthcare Providers & Services industry
Industry Median: 1.545 vs OSTO:RAY B: 3.79

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


RaySearch Laboratories AB PEG Ratio Historical Data

The historical data trend for RaySearch Laboratories AB's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB PEG Ratio Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 260.46 - - - -

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of RaySearch Laboratories AB's PEG Ratio

For the Health Information Services subindustry, RaySearch Laboratories AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's PEG Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's PEG Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's PEG Ratio falls into.



RaySearch Laboratories AB PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

RaySearch Laboratories AB's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=48.179652943178/12.70
=3.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


RaySearch Laboratories AB  (OSTO:RAY B) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


RaySearch Laboratories AB PEG Ratio Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines